Article
Mutations in Rv0678, Rv2535c, and Rv1979c Confer Resistance to Bedaquiline in Clinical Isolates of Mycobacterium Tuberculosis.
Current molecular pharmacology - 1 Jan 2024
Balgouthi Khaoula, AlMatar Manaf, Saghrouchni Hamza, Albarri Osman, Var Işıl
Abstract excerpt
INTRODUCTION: Reduced bedaquiline (BDQ) sensitivity to antimycobacterial drugs has been linked to mutations in the Rv0678, pepQ, and Rv1979c genes of Mycobacterium tuberculosis (MTB). Resistance-causing mutations in MTB strains under treatment may have an impact on novel BDQ-based medication regimens intended to reduce treatment time. Due to this, we investigated the genetic basis of BDQ resistance in Turkish TB...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
